Приказ основних података о документу
Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives
Tečno-čvrsti sistemi kao novi pristup razvoju formulacija i proizvodnji čvrstih farmaceutskih oblika lekova - izazovi i perspektive
dc.creator | Aleksić, Ivana | |
dc.creator | Glišić, Teodora | |
dc.creator | Parojčić, Jelena | |
dc.date.accessioned | 2023-02-01T11:28:16Z | |
dc.date.available | 2023-02-01T11:28:16Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 0004-1963 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/4406 | |
dc.description.abstract | Liquisolid systems are a novel, promising platform for the production of solid dosage forms with a high liquid content, i.e. dispersion of the drug in a suitable, hydrophilic, non-volatile liquid vehicle or liquid drug. This technology requires conventional, but highly porous excipients (carrier and coating material in the appropriate ratio) able to absorb/adsorb liquid medication, resulting in both good flowability and acceptable compression properties. This approach has shown great potential to improve the dissolution rate and bioavailability of poorly soluble drugs, and has been recognized as a good alternative to common, more complex and expensive techniques. A variety of applications of this simple technique have been investigated recently, including the preparation of: modified release tablets, orally disintegrating tablets, solid dosage forms with liquid herbal extracts, etc. This emerging technology has numerous advantages, and the most important are: simplicity, cost-effectiveness, applicability in large scale production and environmental friendliness. However, it is accompanied by certain challenges as well, such as limited applicability in the case of highly dosed drugs. This article aims to give a comprehensive overview of recent progress regarding the potential applications of this technology, as well as to give an insight into the new liquisolid-based techniques intending to further support its commercial applicability. | sr |
dc.description.abstract | Tečno-čvrsti sistemi su nova, obećavajuća platforma za proizvodnju čvrstih farmaceutskih oblika sa visokim sadržajem tečnosti, odnosno disperzije lekovite supstance u pogodnom, hidrofilnom i neisparljivom tečnom vehikulumu ili same lekovite supstance u tečnom agregatnom stanju. Ova tehnologija podrazumeva upotrebu konvencionalnih, ali visoko poroznih ekscipijenasa (nosača i sredstva za oblaganje u odgovarajućem odnosu) koji mogu da absorbuju/adsorbuju tečnost uz zadržavanje dobre protočnosti i prihvatljivih svojstava pri kompresiji. Ovaj pristup je pokazao značajan potencijal da poboljša brzinu rastvaranja i bioraspoloživost slabo rastvorljivih lekovitih supstanci, a prepoznat je kao dobra alternativa uobičajeno primenjivanim, znatno složenijim i skupljim tehnikama. Pored toga, nedavno su istraživane brojne mogućnosti za primenu ove jednostavne tehnike, uključujući izradu: tableta sa modifikovanim oslobađanjem lekovite supstance, oralno disperzibilnih tableta, čvrstih farmaceutskih oblika sa tečnim biljnim ekstraktima, itd. Ova nova tehnologija pruža brojne prednosti, među kojima su najvažnije njena jednostavnost, ekonomičnost, primenljivost u industrijskoj proizvodnji i ekološka prihvatljivost. Međutim, prate je i izvesni izazovi, kao što je ograničena primenljivost u slučaju visoko doziranih lekovitih supstanci. Ovaj rad ima za cilj da pruži sveobuhvatan pregled nedavnog napretka u pogledu potencijalne primene ove tehnologije, kao i da pruži uvid u nove tehnike zasnovane na konceptu tečno-čvrstih sistema koje teže da dalje prošire njenu komercijalnu primenu. | sr |
dc.language.iso | sr | sr |
dc.language.iso | en | sr |
dc.publisher | Pharmaceutical Association of Serbia | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS// | sr |
dc.rights | openAccess | sr |
dc.rights.uri | https://creativecommons.org/licenses/by-sa/4.0/ | |
dc.source | Arhiv za farmaciju | sr |
dc.subject | porous excipients | sr |
dc.subject | tablets | sr |
dc.subject | multiparticulate systems | sr |
dc.subject | poorly soluble drugs | sr |
dc.subject | improved bioavailability | sr |
dc.subject | porozni ekscipijensi | sr |
dc.subject | tablete | sr |
dc.subject | višečestični sistemi | sr |
dc.subject | slabo rastvorljive lekovite supstance | sr |
dc.subject | poboljšana bioraspoloživost | sr |
dc.title | Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives | sr |
dc.title | Tečno-čvrsti sistemi kao novi pristup razvoju formulacija i proizvodnji čvrstih farmaceutskih oblika lekova - izazovi i perspektive | sr |
dc.type | article | sr |
dc.rights.license | BY-SA | sr |
dc.citation.volume | 72 | |
dc.citation.issue | 6 | |
dc.citation.spage | 521 | |
dc.citation.epage | 545 | |
dc.citation.rank | M52 | |
dc.identifier.doi | 10.5937/arhfarm72-40329 | |
dc.identifier.scopus | 2-s2.0-85148246762 | |
dc.identifier.fulltext | http://farfar.pharmacy.bg.ac.rs/bitstream/id/11745/Liquisolid_systems_as_pub_2022.pdf | |
dc.type.version | publishedVersion | sr |